FCI Ophthalmics announces availability of LacriJet for Monocanalicular Nasolacrimal Intubation
FCI Ophthalmics announced the launch of the LacriJet in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector, according to FCI Ophthalmics.